行情

XXII

XXII

22世纪集团
AMEX

实时行情|Nasdaq Last Sale

0.9829
-0.0371
-3.64%
盘后: 1.000 +0.017 +1.74% 17:03 01/29 EST
开盘
1.020
昨收
1.020
最高
1.020
最低
0.9602
成交量
155.46万
成交额
--
52周最高
2.590
52周最低
0.7004
市值
1.24亿
市盈率(TTM)
-4.1915
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

XXII 新闻

  • If You Had Bought 22nd Century Group (NYSEMKT:XXII) Stock A Year Ago, You'd Be Sitting On A 50% Loss, Today
  • Simply Wall St..01/22 18:25
  • 22nd Century Group Appoints New Director and New Chairman
  • GlobeNewswire.01/13 11:45
  • FDA to hold hearing on 22nd Century's VLN cigarettes in February
  • Seeking Alpha - Article.2019/12/23 20:52
  • 22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee
  • GlobeNewswire.2019/12/23 20:39

更多

所属板块

环保服务及设备
-0.12%
专业与商业服务
-0.06%

热门股票

名称
价格
涨跌幅

XXII 简况

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.
展开

Webull提供22nd Century Group Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。